TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05528835

Intervention type: PROCEDURE
Intervention: Frozen embryo transfer
Description: All women in both groups will receive oral estradiol valerate 8 mg/ day from the second day of the menstrual cycle. Endometrial thickness will be assessed by vaginal ultrasonography at the tenth day of treatment. When endometrial thickness reached ≥ 7 mm all subjects, in addition to estrogen, they will receive progesterone vaginal suppositories 400 mg twice daily and 100 mg of progesterone intramuscularly daily. Frozen thawed embryo transfer will be at day 6 of progesterone. Estrogen and progesterone will be continued until 9-10 weeks of gestation

Intervention type: PROCEDURE
Intervention: Frozen embryo transfer
Description: All women in both groups will receive oral estradiol valerate 8 mg/ day from the second day of the menstrual cycle. Endometrial thickness will be assessed by vaginal ultrasonography at the tenth day of treatment. When endometrial thickness reached ≥ 7 mm all subjects, in addition to estrogen, they will receive progesterone vaginal suppositories 400 mg twice daily and 100 mg of progesterone intramuscularly daily. Frozen thawed embryo transfer will be at day 6 of progesterone. Estrogen and progesterone will be continued until 9-10 weeks of gestation
Study: NCT06399848

Intervention type: OTHER
Group type: OTHER
Intervention: Skip one day of peritoneal dialysis treatment
Description: Skip one day of peritoneal dialysis treatment
Study: NCT04868305

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intramedullary nail
Description: Intertan nail (Smith \& Nephew)\* or Gamma 3 nail (Stryker)\*~\* All of the above-mentioned products are subjects to change into an equivalent product

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hip arthroplasty
Description: Total hip arthroplasty:~* Cemented: Lubinus (Link)\*, Exeter (Stryker)\*~* Uncemented: Restoration Modular (Stryker)\*~* Cup: Cemented Avantage dual mobility cup (Zimmer Biomet)\*~Hemiarthroplasty:~* Cemented: Lubinus (Link)\*, Exeter (Stryker)\*~* Uncemented: Restoration Modular (Stryker)\*~  * All of the above-mentioned products are subjects to change into an equivalent product
Study: NCT06360653

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Post-operative Radiotherapy for Endometrial Cancer
Description: Patients candidate to receive adjuvant radiotherapy will be assigned to a shorter schedule of 30 Gy in 5 sessions.
Study: NCT04784026

Intervention type: OTHER
Intervention: Gait assessment (single)
Description: The single walk will be evaluated with a 10-meter walking test and a G-Walk portable device.

Intervention type: OTHER
Intervention: Gait assessment (single)
Description: The single walk will be evaluated with a 10-meter walking test and a G-Walk portable device.

Intervention type: OTHER
Intervention: Dual task gait assessment (motor+motor)
Description: The dual task gait, 10-meter walking test and a motor (carrying a full water glass) will be combined with the task and evaluated with the G-Walk portable device.

Intervention type: OTHER
Intervention: Dual task gait assessment (motor+motor)
Description: The dual task gait, 10-meter walking test and a motor (carrying a full water glass) will be combined with the task and evaluated with the G-Walk portable device.

Intervention type: OTHER
Intervention: Dual tak gait assessment (motor+cognitive)
Description: The dual task gait will be combined with a 10-meter walking test and a cognitive (1-back test) task and evaluated with the G-Walk portable device.

Intervention type: OTHER
Intervention: Dual tak gait assessment (motor+cognitive)
Description: The dual task gait will be combined with a 10-meter walking test and a cognitive (1-back test) task and evaluated with the G-Walk portable device.
Study: NCT04766034

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Simulated Grocery Shopping Exercise
Description: Participants will click a link and simulate a shopping experience by selecting a week's worth of Supplemental Nutrition Assistance Program (SNAP)-eligible groceries for their household in a web-based supermarket platform

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Simulated Grocery Shopping Exercise
Description: Participants will click a link and simulate a shopping experience by selecting a week's worth of Supplemental Nutrition Assistance Program (SNAP)-eligible groceries for their household in a web-based supermarket platform

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Simulated Grocery Shopping Exercise
Description: Participants will click a link and simulate a shopping experience by selecting a week's worth of Supplemental Nutrition Assistance Program (SNAP)-eligible groceries for their household in a web-based supermarket platform

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Simulated Grocery Shopping Exercise
Description: Participants will click a link and simulate a shopping experience by selecting a week's worth of Supplemental Nutrition Assistance Program (SNAP)-eligible groceries for their household in a web-based supermarket platform
Study: NCT05289154

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: self- applied acupressure plus Qigong course plus advice literature
Description: daily self applied acupressure over 20min plus 2 times per week online live Qigong course of each 45min- both over 8 weeks.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: advice literature with naturopathy
Description: advice literature with naturopathic remedies will be handed out and application will be supported with dairies and phone calls
Study: NCT05502692

Intervention type: BEHAVIORAL
Intervention: CHARACTERISE
Description: Cohort 1 Cohort 2

Intervention type: BEHAVIORAL
Intervention: CHARACTERISE
Description: Cohort 1 Cohort 2
Study: NCT05525793

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transitional care model
Description: The patients who were assigned to this group with the transitional care model, 6 weeks of counseling and intervention training provided continuity of care and a safe transition, and patients were encouraged about symptom management and a healthy lifestyle.
Study: NCT05255874

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aromatherapy
Description: Patients in the study group will rest for 5 minutes before and after the urodynamics procedure. All patients will be asked to fill in the 'Spielberger State Anxiety Scale' before and after the urodynamic procedure. Before and after the procedure, blood pressure, heart rate, respiratory rate, peripheral oxygen saturation will be measured. Blood will be drawn for serum cortisol level. In addition to the routine treatment and care practices of the unit, aromatherapy will be applied to the patients included in the study group. Aromatherapy application will be applied to all patients by the same researcher. Aromatherapy application will be started 5 minutes before the urodynamic procedure after the patient is taken to the urodynamic room, and lavender essential oil (3 drops in 300 cc water for 5 cubic meters of room) will be used with a diffuser until the end of the procedure.
Study: NCT05850988

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: %80 Oxygen concentration
Description: Patients will be administered %80 Oxygen for 3 minutes during preoxygenation.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: %100 Oxygen concentration
Description: Patients will be administered %100 Oxygen for 3 minutes during preoxygenation.
Study: NCT05286723

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicomponent Training
Description: Warm up, aerobic training, stenght training, balance and coordination training and return to calm
Study: NCT05691686

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Finely milled whole wheat-legume bread
Description: The intervention examines the effect of finely milled wheat-legume bread in subjects with normal body weight.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Less processed whole wheat-legume bread
Description: The intervention examines the effect of less processed whole wheat-legume bread in subjects with normal body weight.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Less processed whole wheat bread
Description: The intervention examines the effect of less processed whole wheat bread in subjects with normal body weight.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: White wheat bread
Description: The intervention examines the reference food product in subjects with normal body weight.
Study: NCT06420544

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: JAPI: Cognitive, Emotional and Social Stimulation for Preschool Children
Description: Those children in the intervention group will play with the gaming platform Japi using a tablet device in a designated time given from schools' authorities. Early Year Educators will be present to help with the discipline and motivation of the students and Research Assistants will be there as well to provide technical support for the use of the equipment.~The intervention has 24 sessions, and the dosage will be two sessions of 15 minutes each per week for 12 weeks. Sessions number 1 to number 8 are focused on emotional regulation and inhibitory control. Sessions number 9 to 16 work on working memory and problem-solving. Sessions number 17 to 24 promote empathy and planification skills. Each session will have eight activities with increasing levels of difficulty.
Study: NCT05291039

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Infliximab
Description: group 1 (n=20): patients will receive IFX

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adalimumab
Description: group 2 (n=20): patients will receive ADA
Study: NCT06413368

Intervention type: DRUG
Group type: OTHER
Intervention: Maralixibat 9.5 MG/ML [Livmarli]
Description: Within Study subjects receiving 2 weeks of treatment with Maralixibat 9.5 MG/ML \[Livmarli\] and compare to baseline treatment.
Study: NCT05527912

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy
Description: All subjects received two courses of the following treatment:~Rituximab ，375mg/m²， D1； Chidamiade ，20mg ，biw， d1-14； Zanubrutinib ，160mg， bid， d1-21；~three weeks for a period of treatment, all subjects complete tumor assessment after two courses of treatment, patients which achieve complete remission continue for up to 8 sessions, patients achieve partial response and stable disease combined use of the following CHOP threapy to 6 courses, Patients with progressive disease dropped out of this research.~CHOP Therapy:~Cyclophosphamide， 750mg/m² ，D1； Vincristine， 1.4mg/m² ，D1 (maximum：2mg)； Doxorubicin or pirarubicin， 50mg/m²， D1； Prednisone ，30mg ，tid， D1-5.
Study: NCT04688931

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UGN-102
Description: UGN-102 consists of mitomycin and sterile hydrogel (a proprietary thermally responsive gel) that is used to reconstitute mitomycin before instillation. The reverse thermal properties of UGN-102 allow for local administration of mitomycin as a liquid under chilled conditions, with subsequent conversion to a semi-solid gel depot following instillation into the bladder.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TURBT
Description: The current standard of care for treatment of LG-IR-NMIBC is TURBT under general anesthesia.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TURBT
Description: The current standard of care for treatment of LG-IR-NMIBC is TURBT under general anesthesia.
Study: NCT05837455

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anastrozole
Description: Standard of care

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination anthracycline and/or taxane based treatment
Description: Standard of care
Study: NCT06084962

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DeepTag-GPRC5D Targeted CAR T-cells
Description: Each subject receive DeepTag-GPRC5DTargeted CAR T-cells by intravenous infusion
Study: NCT04513314

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Valproate
Description: Valproate sodium (enteral or intravenous) will be administered at a dosage of 10 to 15 mg/kg/day. The dosage may be increased by 5 to 10 mg/kg/week to achieve optimal clinical response. Ordinarily, optimal clinical response is achieved at daily doses below 60 mg/kg/day.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Quetiapine
Description: Enteral quetiapine dosing on Day 3: 25 mg to 50 mg twice daily. Increase in increments of 50 mg/day to 100 mg/day divided two on Days 4 and 5 to range of 50-400 mg/day by Day 7. Further adjustments can be made in increments of 25-50 mg twice a day, in intervals of not less than 2 days. Recommended dose range is 150-750 mg/day.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Standard of Care is a combination of IV dexmedetomidine (D), midazolam (M), ketamine (K) and propofol (P), at the discretion of treating physician.
Study: NCT05730946

Intervention type: DIAGNOSTIC_TEST
Intervention: Interview- based questionnaire
Description: Interview-based questionnaire by the use of an interview guide to explore and understand the Challenges faced in the past and the concerns for the future experienced by parents of CLP patients.
Study: NCT04962672

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol group
Description: 20 patients scheduled for the elective craniotomy for suspected high-grade gliomas resection will be enrolled and further randomized to receive total intravenous anesthesia (propofol group). Standard fasting and monitoring guidelines will be instituted. All patients will be induced and intubated after administration of intravenous boluses of fentanyl, propofol and rocuronium. For the maintenance phase of anesthesia, patients in the propofol group will receive continuous infusions of propofol and remifentanil. No patients will receive nitrous oxide. Anesthesia will be titrated to keep depth of anesthesia between 35- 55. All patients will be maintained on oxygen in air mixture (40%) and titrate the End Tidal Carbon Dioxide (ETCO2) concentration between 25-30 mm Hg.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane group
Description: 20 patients scheduled for the elective craniotomy for suspected high-grade gliomas resection will be enrolled and further randomized to receive Volatile (sevoflurane group) agent for the maintenance phase of anesthesia. Standard fasting and monitoring guidelines will be instituted. All patients will be induced and intubated after administration of intravenous boluses of fentanyl, propofol and rocuronium. For the maintenance phase of anesthesia, patients in the volatile inhalational anesthesia group received a volatile inhalational agent (sevoflurane) and remifentanil infusion. No patients will receive nitrous oxide. Anesthesia will be titrated to keep depth of anesthesia between 35- 55. All patients will be maintained on oxygen in air mixture (40%) and titrate the End Tidal Carbon Dioxide (ETCO2) concentration between 25-30 mm Hg.
Study: NCT05915325

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Physical training
Description: 1. Supervised Physical Training in SeniorGym for 12 weeks: 1) Aerobic exercise: Patient-tailored intensity-modulated ergometer training for the limbs; 2) Resistance exercise: Patient-tailored resistance exercise by Theraband for the limbs~2. Nutrition intervention for 24 weeks: Dietitian consultation, education and intervention for 24 weeks
Study: NCT06045728

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pilates exercises
Description: Pilates is a group of low impact muscle exercises that strengthen abdominal muscles, back, hips and pelvic floor muscles. the exercise consists of 10 min warm up, 40 min exercise and 10 min cooling down. the exercises that will be included: spine twist, double leg stretch, double leg circles, side leg circle, curl up, shoulder bridges and pelvic curl.

Intervention type: OTHER
Group type: OTHER
Intervention: Pilates exercises
Description: Pilates is a group of low impact muscle exercises that strengthen abdominal muscles, back, hips and pelvic floor muscles. the exercise consists of 10 min warm up, 40 min exercise and 10 min cooling down. the exercises that will be included: spine twist, double leg stretch, double leg circles, side leg circle, curl up, shoulder bridges and pelvic curl.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean diet
Description: it is a type of diet used for obesity management based on high vegetable intake, olive oil as a source of fat, the consumption of grains, legumes, and nuts with high amounts of pulp, low-medium consumption of fish, low consumption of red meat.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mediterranean diet
Description: it is a type of diet used for obesity management based on high vegetable intake, olive oil as a source of fat, the consumption of grains, legumes, and nuts with high amounts of pulp, low-medium consumption of fish, low consumption of red meat.
Study: NCT04513314

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Standard of Care is a combination of IV dexmedetomidine (D), midazolam (M), ketamine (K) and propofol (P), at the discretion of treating physician.
Study: NCT04831567

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MIBG-I131
Description: Radiopharmaceutical
Study: NCT04745130

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab，regofinib，cetuximab
Description: KRAS BRAF wild type Sintilimab 200mg d1q3w+ regofinib 80mg d1-21 q4w with cetuximab 500mg/m2 q2w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KRAS BRAF mutant Sintilimab + regafinil
Description: KRAS BRAF mutant Sintilimab 200mg D1 Q3W + regafinil 80mg D1-21 Q4W
Study: NCT04950998

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Moving Up - A
Description: Moving Up - A is a physical activity smartphone app for persons with mild cognitive impairment or mild forms of dementia. The app includes a personally tailored set of messages, tips, strategies, and tasks designed to increase physical activity levels and disrupt extended periods of sedentary time. Users also have the ability to track their steps and and sedentary behavior time as well as their progress towards activity goals.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Moving Up - A
Description: Moving Up - A is a physical activity smartphone app for persons with mild cognitive impairment or mild forms of dementia. The app includes a personally tailored set of messages, tips, strategies, and tasks designed to increase physical activity levels and disrupt extended periods of sedentary time. Users also have the ability to track their steps and and sedentary behavior time as well as their progress towards activity goals.
Study: NCT05091047

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Erchonia EVRL
Description: 42 procedure administrations with the Erchonia® EVRL™ administered by the subject at home: Twice daily procedure administrations for 3 weeks.
Study: NCT05248048

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR-T infusion
Description: NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
Study: NCT06290479

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Air Up® Peach Pod
Description: Participants in this arm will use the air up® drinking system with a peach-flavored pod.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Air Up® Orangeade Pod
Description: Participants in this arm will use the air up® drinking system with an orangeade-flavored pod.
Study: NCT04883931

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: 0.5 ml 0.9% normal saline will drop on both eyes twice in a day.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Breast milk
Description: 0.5 ml breast milk from all infant's own mother will drop both eyes twice in a day
Study: NCT05417139

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Immunotherapy+induction chemotherapy+radiotherapy
Description: All enrolled patients received Sintilimab (200mg, d1, q3w) + GP (gemcitabine 1000mg / m2, d1, d8 + cisplatin 80mg / m2, d1, q3w) for 4-6 cycles followed by radiotherapy of primary site and cervical metastasis, and Sintilimab (200mg, q3w) treatment was continued during and after radiotherapy until disease progression or toxicity or up to 2 years.
Study: NCT04313088

Intervention type: DRUG
Group type: OTHER
Intervention: Eluxadoline 100 mg
Description: Eluxadoline 100mg by mouth twice daily with food
Study: NCT06388239

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban 5MG
Description: Apixaban 5 mg Film-coated tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Apixaban 5MG
Description: Apixaban 5 mg Film-coated tablets
Study: NCT05246878

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDP-235
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDP-235
Description: Oral administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match EDP-235, oral administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match EDP-235, oral administration
Study: NCT04089852

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrous oxide gas for inhalation
Description: All inhaled gases will be administered via nasal mask using a portable nitrous oxide/oxygen (N2O/O2) machine. Environmental safety will be maintained with an N2O scavenger system and Porter Miniature Vacuum System. The treatment group will receive inhaled N2O/O2. The N2O will be gradually up-titrated to a goal ratio of 70/30 N2O/O2 and will be administered as outlined in the treatment arm description.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oxygen Gas for Inhalation
Description: All inhaled gases will be administered via nasal mask using a portable nitrous oxide/oxygen (N2O/O2) machine. The control group will receive inhaled O2 alone. Control group participants will receive 100% O2 for two minutes prior to speculum placement. Inhaled oxygen will be administered continuously throughout the procedure as outlined in the control arm description.
Study: NCT05848076

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TNE
Description: McGill exercise focuses on the ability of the spine to stabilize in different positions 3 sets of 3 repletion with of each of muscle and briefly explains the patient about their pain

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: core stability
Description: McGill exercises for the low back.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core stability
Description: McGill exercises for the low back.
Study: NCT04227626

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GlucoSTAT
Description: Closed-loop blood glucose control using intravenous insulin and dextrose
Study: NCT05841719

Intervention type: OTHER
Group type: OTHER
Intervention: Screening test
Description: Capillary blood sampling by finger-prick devices and second confirmatory venous sampling when needed.